| ■ Novartis Starts Swine Flu Vaccine Test in Humans | 2009.08.08 |
| The first human trial of a swine flu vaccine made by Swiss drugmaker Novartis started about 10 days ago when a person in Britain received the first shot. The year-long trial will include 6,000 participants of all ages in Britain, Germany and the United States, drug company spokesman Eric Althoff told the Associated Press. He added that the vaccine will likely be on the market before the trial is completed. The trial is designed to test the safety of the vaccine and to determine whether people require one or two shots. "Our assumption is that two doses will be required," Althoff told the AP. Since swine flu was declared a pandemic by the World Health Organization in June, drug companies have been striving to get their vaccines ready. In July, Australian drugmaker CSL became the first to start testing a swine flu vaccine in humans. |